Strangert 1969.
Methods | Quasi‐randomised controlled trial | |
Participants | Inclusion criteria: children admitted with clinical pertussis Exclusion criteria: children who received chloramphenicol or ampicillin prior to their stay in hospital or were discharged before the course of therapy had been completed | |
Interventions | Treatment group: ampicillin 75 to 100 mg/kg/day divided in 4 doses for 6 days Controlled group: chloramphenicol 75 to 100 mg/kg/day divided in 4 doses for 6 days Children under 6 months of age were also given immunoglobulin against whooping cough each other day on altogether 3 occasions | |
Outcomes | Microbiological eradication, adverse reactions, complications (secondary infections) | |
Notes | This is quasi‐randomised study for treatment of pertussis. Immunisation status not stated | |
Risk of bias | ||
Bias | Authors' judgement | Support for judgement |
Random sequence generation (selection bias) | High risk | Method of randomisation: alternation of patients (each second child admitted with whooping cough was treated with ampicillin) |
Allocation concealment (selection bias) | High risk | High risk |
Blinding (performance bias and detection bias) All outcomes | High risk | Blinding of intervention: no. Blinding of outcome measure: no |
Incomplete outcome data (attrition bias) All outcomes | High risk | Complete follow up: no |
Selective reporting (reporting bias) | High risk |
DTP: diphtheria‐tetanus‐pertussis EST: erythromycin estolate ETH: erythromycin ethylsuccinate t.d.s: three times a day